COLONY GROUP LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 313 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
COLONY GROUP LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$1,452
-62.3%
89,926
-3.0%
0.02%
-60.0%
Q2 2023$3,849
+1530.9%
92,753
+2258.9%
0.06%
+1733.3%
Q1 2023$236
-96.9%
3,932
-96.2%
0.00%
-97.2%
Q4 2022$7,611
-99.9%
103,763
+13.0%
0.11%
-13.0%
Q3 2022$6,974,000
+9.0%
91,793
-0.3%
0.12%
+11.8%
Q2 2022$6,401,000
-12.0%
92,096
+5.0%
0.11%
+0.9%
Q1 2022$7,270,000
+17.3%
87,749
+6.3%
0.11%0.0%
Q4 2021$6,199,000
-34.8%
82,568
+1.0%
0.11%
-40.1%
Q3 2021$9,501,000
-51.6%
81,782
-7.5%
0.18%
-53.3%
Q2 2021$19,616,000
+57.5%
88,433
-6.1%
0.39%
+48.9%
Q1 2021$12,452,000
-26.8%
94,206
-4.2%
0.26%
-33.3%
Q4 2020$17,022,000
+50.7%
98,370
-3.0%
0.39%
+33.7%
Q3 2020$11,293,000
+79.2%
101,458
-4.5%
0.29%
+61.5%
Q2 2020$6,303,000
-15.4%
106,283
-3.9%
0.18%
-24.8%
Q1 2020$7,448,000
-23.1%
110,609
-3.8%
0.24%
-1.2%
Q4 2019$9,689,000
+9.2%
114,979
-3.1%
0.24%
-13.1%
Q3 2019$8,875,000
+1.3%
118,687
-14.4%
0.28%
+1.4%
Q2 2019$8,765,000138,6270.28%
Other shareholders
NOVOCURE LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Nordwand Advisors, LLC 1,515,000$111,125,24913.86%
Invus Financial Advisors, LLC 350,884$25,737,34113.70%
HARTLINE INVESTMENT CORP/ 304,482$22,333,7555.08%
GREAT POINT PARTNERS LLC 241,000$17,677,3503.46%
Tri Locum Partners LP 72,400$5,311,0002.15%
Taylor Frigon Capital Management LLC 42,061$3,085,1741.75%
HighVista Strategies LLC 28,007$2,054,3131.22%
HAP Trading, LLC 124,500$10,2941.05%
Private Harbour Investment Management & Counsel, LLC 12,285$901,1050.99%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 32,000$2,344,0000.72%
View complete list of NOVOCURE LTD shareholders